Generali Investments Towarzystwo Funduszy Inwestycyjnych
Position in BMY — Bristol Myers Squibb Co
CIK 2043130
WARSAW, R9
Position in BMY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$605,010
+$180,460 QoQ
Shares Held
10,500
+50.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#1,425
of 2,506 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Generali Investments Towarzystwo Funduszy Inwestycyjnych holds $8,405,860 across 8 Drug Manufacturers - General names. BMY ranks #6 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
87,000 | $2,094,960 | |
| 2 | LLY |
ELI LILLY & Co
|
1,510 | $1,811,139 | |
| 3 | MRK |
Merck & Co., Inc.
|
14,000 | $1,799,000 | |
| 4 | AMGN |
Amgen Inc
|
2,500 | $905,300 | |
| 5 | JNJ |
Johnson & Johnson
|
3,100 | $787,307 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
10,500 | $605,010 | |
| 7 | ABBV |
AbbVie Inc.
|
1,100 | $276,804 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,000 | $126,340 |
All Filings in BMY
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $605,010 | 10,500 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $424,550 | 7,000 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $377,580 | 7,000 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $239,030 | 5,300 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $212,934 | 4,600 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $280,554 | 4,600 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $260,176 | 4,600 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $253,526 | 4,900 | Shares | Sole | 2025-02-05 | |
| 2024-06-30 | $203,497 | 4,900 | Shares | Sole | 2025-02-05 | |
| 2024-03-31 | $265,727 | 4,900 | Shares | Sole | 2025-02-05 | |
| 2023-12-31 | $251,419 | 4,900 | Shares | Sole | 2025-02-05 | |
| 2023-09-30 | $284,396 | 4,900 | Shares | Sole | 2025-02-05 | |
| 2023-06-30 | $217,430 | 3,400 | Shares | Sole | 2025-02-05 | |
| 2023-03-31 | $214,861 | 3,100 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||